My guess - 2 yrs before it lands with the FDA for registration. Then up to 1 yr for product launch. A few cap raises to go by then. Will be pretty much fast tracked by FDA and near about everyone else given it is cancer we are talking about and even worse, pancreatic cancer. Patient numbers don't have to be many since we are looking at increase in survival time. There is not much ambiguity there...the parrot cannot be resting.
But wait there is more!!
Near about any growth that needs busting can use this treatment..all kinds of tumors, even benign growth if proved safe.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
0.000(0.00%) |
Mkt cap ! $16.42M | |||
| Open | High | Low | Value | Volume |
| $1.19 | $1.20 | $1.15 | $28.02K | 24.12K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13404 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 11408 | 1 |
View Market Depth
| Last trade - 14.37pm 30/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |